2-minute pitch for my startup Cathedral Therapeutics (co-founded with David Curiel)! If you’re interested, please feel free to reach out.
Cathedral’s novel technology protects adeno-associated virus (AAV) gene therapies from the immune system so that all patients can access the life-changing cures they need. We encapsulate AAVs inside of hollow organelles found in human cells called protein vaults to make vaultAAV complexes. This approach shields the encapsulated AAVs from antibodies so that they can enter cells and deliver beneficial DNA. https://www.cathedraltherapeutics.com/